Dear Colleagues and Friends,
We are delighted to extend our warmest invitation to the MPN-MDS Focus Meeting 2024, to be held at on August 30 - 31, 2024.
Centered around the theme “Updating Knowledge & Clinical Practice in 2024” this meeting provides pivotal collaboration aimed at advancing MPN-MDS research and patient treatment.
This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.
Chairs of MPN-MDS Focus Meeting 2024:
Rami Komrokji, MD
Moffitt Cancer Center, Tampa, FL
Dr. Alessandro M. Vannucchi
University of Florence, Italy
What do Our Chairs Think?
Rami Komrokji, MD
Dr. Alessandro M. Vannucchi
Supporters to be announced...
Interested in supporting this meeting? Get in contact:
cristina.anton@md-education.comAgenda & Faculty
August 30, 2024 | Day 1
Matteo Della Porta, MD
Humanitas University, ItalySession 1: Mutations and Classification of MPN and MDS
Tiziano Barbui, MD
Foundation of Clinical Research, Ospedale Papa Giovanni XXIII, Bergamo, Italy
Maria Teresa Voso, MD
Rome Tor Vergata University, Italy
Mrinal S. Patnaik, MD
Mayo Clinic, Cleveland, OH
Ruben Mesa, MD
MD Anderson Cancer Center, Houston, TXSession 2: Polycythemia Vera (PV)
Debate: Is Leukocytosis Important in PV?
Heinz Gisslinger, MD
Medical University of Vienna, Austria
Rajko Kušec, MD
Dubrava University Hospital, CroatiaDebate: How Real-world Data Inform the Treatment of PV
Jean-Jacques Kiladjian, MD
Université Paris Cité, France
Steffen Koschmieder, MD
University Hospital RWTH Aachen, Aachen, GermanySession 3: Essential Thrombocytopenia (ET) and Special Situations
Martin Griesshammer, MD
D Ruhr-Universität Bochum, Germany
Mary Frances McMullin, MD
Queen’s University Belfast, Ireland
Ivana Urošević, MD
Clinical Centre of Vojvodina, Novi Sad, SerbiaSession 4: Myelofibrosis
Haifa Kathrin Al-Ali, MD
University Hospital Halle, Germany
Massimo Breccia, MD
AOU Policlinico Umberto I, ItalyDr. Alessandro M. Vannucchi
University of Florence, ItalyAugust 31, 2024 | Day 2
Session 5: Other MPNs & Co
Deepti Radia, MD
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Andreas Reiter, MD
University Medical Centre Mannheim, Germany
Carmelo Gurnari, MD
Cleveland Clinic, Cleveland, OH
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TXSession 6: MDS/MPN Overlap Syndromes
Eric Solary, MD
Université Paris-Saclay, FranceRami Komrokji, MD
Moffitt Cancer Center, Tampa, FLMrinal S. Patnaik, MD
Mayo Clinic, Cleveland, OHSession 7: Myelodysplastic Syndromes (MDS)
Matteo Della Porta, MD
Humanitas University, Italy
Valeria Santini, MD
University of Florence, Italy
Uwe Platzbecker, MD
University Hospital in Leipzig, Germany
Michael R. Savona, MD
Vanderbilt University Medical Center, Nashville, TXSession 8: Hematopoietic Stem Cell Transplantation (HSCT) & MRD Assessment
María Julia Montoro Gómez, MD
Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain
Thomas Cluzeau, MD
Centre Hospitalier Universitaire de Nice, France
Anne Kubasch, MD
University Hospital in Leipzig, GermanySession 9: Hematopoietic Stem Cell Transplantation (HSCT) & MRD Assessment
Nicolaus Kröger, MD
University Medical Center, Hamburg - Eppendorf, Germany
Francesco Mannelli, MD
University of Florence, Italy
Astrid Marta Olsnes, MD
MD Anderson Cancer Center, Houston, TX
Paola Guglielmelli, MD
University of Florence, ItalyDebate: HSCT for MDS: Do we Need Treatment Before and After?
Uwe Platzbecker, MD
University Hospital in Leipzig, GermanyNicolaus Kröger, MD
University Medical Center, Hamburg - Eppendorf, GermanyCristina Anton
Project Manager
How long has Cristina Anton been in the business?
Cristina Anton has been with MD Education since 2022
About Cristina Anton
I’m Romanian but have lived in the UK since 2015, serving as a Project Manager at MD Education's Wigan office since 2022. I have a diverse career background across various sectors, which has enriched my approach to project management. I’m dedicated and committed to excellence and I thrive on opportunities for personal and professional growth.
